MoHFW prohibited the manufacture, sale, and distribution of the drug fixed dose combination of Salbutamol + Bromhexine

Jun 03, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Ministry of Health and Family Welfare (MoHFW) on June 02, 2023, issued a notification regarding the prohibition of the manufacture, sale, or distribution of drugs for human use the fixed-dose combination of Salbutamol + Bromhexine

This shall come into force on June 02, 2023

The following has been stated namely: -

• This is in supersession of the notification of the Government of India, Ministry of Health and Family Welfare Notification number S.O. 978(E), dated March 10, 2016, 

• It has been decided to prohibit the manufacture for sale, sale, or distribution for human use of drug fixed dose combination of  Salbutamol + Bromhexine with immediate effect

 

[Notification No. S.O. 2403(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT